HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 275, Issue 38, 29547-29555, September 22, 2000

This Article Full Text Full Text (PDF) All Versions of this Article: 275/38/29547    most recent M910023199v1 Submit a Letter to Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jensen, A. A. Articles by Bräuner-Osborne, H. Search for Related Content PubMed PubMed Citation Articles by Jensen, A. A. Articles by Bräuner-Osborne, H. Social Bookmarking                      What's this?

Functional Importance of the Ala¹¹⁶-Pro¹³⁶ Region in the Calcium-sensing Receptor
CONSTITUTIVE ACTIVITY AND INVERSE AGONISM IN A FAMILY C G-PROTEIN-COUPLED RECEPTOR^*

Anders A. Jensen, Tracy A. Spalding^§, Ethan S. Burstein^§, Paul O. Sheppard^¶, Patrick J. O'Hara^¶, Mark R. Brann^§, Povl Krogsgaard-Larsen, and Hans Bräuner-Osborne

From the  NeuroScience PharmaBiotec Research Centre, Department of Medicinal Chemistry, The Royal Danish School of Pharmacy, 2 Universitetsparken, DK-2100 Copenhagen, Denmark, ^§ ACADIA Pharmaceuticals Inc., San Diego, California, 92121, and the ^¶ ZymoGenetics Inc., Seattle, Washington 98102

The calcium-sensing receptor (CaR) belongs to family C of the G-protein-coupled receptor superfamily. To date 14 activating mutations in CaR showing increased sensitivity to Ca²⁺ have been identified in humans with autosomal dominant hypocalcemia. Four of these activating mutations are found in the Ala¹¹⁶-Pro¹³⁶ region of CaR, indicating that this part of the receptor is particularly sensitive to mutation-induced activation. This region was subjected to random saturation mutagenesis, and 219 mutant receptor clones were isolated and screened pharmacologically in a high throughput screening assay. Selected mutants were characterized further in an inositol phosphate assay. The vast majority of the mutants tested displayed an increased affinity for Ca²⁺. Furthermore, 21 of the mutants showed increased basal activity in the absence of agonist. This constitutive activity was not diminished when the mutations were transferred to a chimeric receptor Ca/1a consisting of the amino-terminal domain of the CaR and the 7 transmembrane and intracellular domains of the metabotropic glutamate receptor mGluR1a. CPCCOEt, a noncompetitive antagonist acting at the 7 transmembrane domain of mGluR1a, suppressed the elevated basal response of the constitutively activated Ca/1a mutants demonstrating inverse agonist activity of CPCCOEt. Taken together, our results demonstrate that the Ala¹¹⁶-Pro¹³⁶ region is of key importance for the maintenance of the inactive conformation of CaR.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				R. A. Bakker, A. Jongejan, K. Sansuk, U. Hacksell, H. Timmerman, M. R. Brann, D. M. Weiner, L. Pardo, and R. Leurs Constitutively Active Mutants of the Histamine H1 Receptor Suggest a Conserved Hydrophobic Asparagine-Cage That Constrains the Activation of Class A G Protein-Coupled Receptors Mol. Pharmacol., January 1, 2008; 73(1): 94 - 103. [Abstract] [Full Text] [PDF]

				M. M. Dvorak, T.-H. Chen, B. Orwoll, C. Garvey, W. Chang, D. D. Bikle, and D. M. Shoback Constitutive Activity of the Osteoblast Ca2+-Sensing Receptor Promotes Loss of Cancellous Bone Endocrinology, July 1, 2007; 148(7): 3156 - 3163. [Abstract] [Full Text] [PDF]

				R. S. Mukherjee, E. W. McBride, M. Beinborn, K. Dunlap, and A. S. Kopin Point Mutations in Either Subunit of the GABAB Receptor Confer Constitutive Activity to the Heterodimer Mol. Pharmacol., October 1, 2006; 70(4): 1406 - 1413. [Abstract] [Full Text] [PDF]

				B. J. Arey, R. Seethala, Z. Ma, A. Fura, J. Morin, J. Swartz, V. Vyas, W. Yang, J. K. Dickson Jr., and J. H. M. Feyen A Novel Calcium-Sensing Receptor Antagonist Transiently Stimulates Parathyroid Hormone Secretion in Vivo Endocrinology, April 1, 2005; 146(4): 2015 - 2022. [Abstract] [Full Text] [PDF]

				L. Silvotti, G. Giannini, and R. Tirindelli The Vomeronasal Receptor V2R2 Does Not Require Escort Molecules for Expression in Heterologous Systems Chem Senses, January 1, 2005; 30(1): 1 - 8. [Abstract] [Full Text] [PDF]

				K. Ray, S. P. Ghosh, and J. K. Northup The Role of Cysteines and Charged Amino Acids in Extracellular Loops of the Human Ca2+ Receptor in Cell Surface Expression and Receptor Activation Processes Endocrinology, August 1, 2004; 145(8): 3892 - 3903. [Abstract] [Full Text] [PDF]

				C. Petrel, A. Kessler, F. Maslah, P. Dauban, R. H. Dodd, D. Rognan, and M. Ruat Modeling and Mutagenesis of the Binding Site of Calhex 231, a Novel Negative Allosteric Modulator of the Extracellular Ca2+-sensing Receptor J. Biol. Chem., December 5, 2003; 278(49): 49487 - 49494. [Abstract] [Full Text] [PDF]

				R. Vargas-Poussou, C. Huang, P. Hulin, P. Houillier, X. Jeunemaitre, M. Paillard, G. Planelles, M. Dechaux, R. T. Miller, and C. Antignac Functional Characterization of a Calcium-Sensing Receptor Mutation in Severe Autosomal Dominant Hypocalcemia with a Bartter-Like Syndrome J. Am. Soc. Nephrol., September 1, 2002; 13(9): 2259 - 2266. [Abstract] [Full Text] [PDF]

				K. Sato, Y. Hasegawa, J. Nakae, K. Nanao, I. Takahashi, T. Tajima, N. Shinohara, and K. Fujieda Hydrochlorothiazide Effectively Reduces Urinary Calcium Excretion in Two Japanese Patients with Gain-of-Function Mutations of the Calcium-Sensing Receptor Gene J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3068 - 3073. [Abstract] [Full Text] [PDF]

				T. A. Spalding, C. Trotter, N. Skjarbak, T. L. Messier, E. A. Currier, E. S. Burstein, D. Li, U. Hacksell, and M. R. Brann Discovery of an Ectopic Activation Site on the M1 Muscarinic Receptor Mol. Pharmacol., June 1, 2002; 61(6): 1297 - 1302. [Abstract] [Full Text] [PDF]

				A. Lienhardt, M. Bai, J.-P. Lagarde, M. Rigaud, Z. Zhang, Y. Jiang, M.-L. Kottler, E. M. Brown, and M. Garabedian Activating Mutations of the Calcium-Sensing Receptor: Management of Hypocalcemia J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5313 - 5323. [Abstract] [Full Text] [PDF]

				F. Y. Carroll, A. Stolle, P. M. Beart, A. Voerste, I. Brabet, F. Mauler, C. Joly, H. Antonicek, J. Bockaert, T. Müller, et al. BAY36-7620: A Potent Non-Competitive mGlu1 Receptor Antagonist with Inverse Agonist Activity. Mol. Pharmacol., April 16, 2001; 59(5): 965 - 973. [Abstract] [Full Text]

				A. A. Jensen, P. O. Sheppard, L. B. Jensen, P. J. O'Hara, and H. Brauner-Osborne Construction of a High Affinity Zinc Binding Site in the Metabotropic Glutamate Receptor mGluR1. NONCOMPETITIVE ANTAGONISM ORIGINATING FROM THE AMINO-TERMINAL DOMAIN OF A FAMILY C G-PROTEIN-COUPLED RECEPTOR J. Biol. Chem., March 23, 2001; 276(13): 10110 - 10118. [Abstract] [Full Text] [PDF]

				G. Reyes-Cruz, J. Hu, P. K. Goldsmith, P. J. Steinbach, and A. M. Spiegel Human Ca2+ Receptor Extracellular Domain. ANALYSIS OF FUNCTION OF LOBE I LOOP DELETION MUTANTS J. Biol. Chem., August 17, 2001; 276(34): 32145 - 32151. [Abstract] [Full Text] [PDF]